Orexo
Develops pharmaceuticals and digital therapies for substance use and mental health.
ORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000736415 (+2 more)
- LEI:
- 549300LJ5CCWDPTK9Z08
- Country:
- Sweden
- Address:
- Box 303, 751 05 UPPSALA
- Website:
- https://orexo.com/
- Sector:
- Manufacturing
Description
Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2014-06-27 08:00 |
Orexo stämmer Actavis för patentintrång
|
Swedish | 322.1 KB | ||
| 2014-06-27 08:00 |
Orexo commences patent infringement litigation against Actavis
|
English | 325.7 KB | ||
| 2014-06-25 08:30 |
Top-line data from a Phase 3 clinical trial demonstrates that Zubsolv® is as ef…
|
English | 116.5 KB | ||
| 2014-06-25 08:30 |
Klinisk studie visar att Zubsolv® (buprenorfin/naloxon sublingual tablett) är l…
|
Swedish | 115.6 KB | ||
| 2014-06-23 08:32 |
Positive Top-line Results from Two Phase 3 Clinical Trials that Assessed Zubsol…
|
English | 360.1 KB | ||
| 2014-06-23 08:30 |
Positiva resultat från två kliniska Fas 3 studier som utvärderat Zubsolv® för i…
|
Swedish | 356.5 KB | ||
| 2014-06-09 17:30 |
Orexo offentliggör obligationsprospekt och ansöker om inregistrering av sitt ob…
|
Swedish | 327.3 KB | ||
| 2014-06-09 17:30 |
Orexo publishes bond prospectus and applies for listing of its bond loan on NAS…
|
English | 316.9 KB | ||
| 2014-05-30 16:30 |
Antal aktier och röster i Orexo
|
Swedish | 321.0 KB | ||
| 2014-05-30 16:30 |
Number of shares and votes in Orexo
|
English | 313.5 KB | ||
| 2014-05-20 08:00 |
Orexo ingår nytt samarbete för kommersialiseringen av Zubsolv® i USA
|
Swedish | 339.8 KB | ||
| 2014-05-20 08:00 |
Orexo announces new partner for the commercialization of Zubsolv® in the United…
|
English | 336.5 KB | ||
| 2014-05-12 08:15 |
Orexo har slutfört sin obligationsemission om 500 MSEK
|
Swedish | 247.0 KB | ||
| 2014-05-12 08:15 |
Orexo has completed its SEK 500 million bond issue
|
English | 249.8 KB | ||
| 2014-04-30 13:15 |
Orexo issues a SEK 500 million bond loan on the Swedish bond market
|
English | 319.3 KB |
Automate Your Workflow. Get a real-time feed of all Orexo filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Orexo
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Orexo via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-11 | Nikolaj Arrild Sørensen | Other | Buy | 2,460 | 35,178.00 SEK |
| 2025-04-04 | Nikolaj Arrild Sørensen | Other | Buy | 3,500 | 47,530.00 SEK |
| 2024-03-26 | Fredrik Järrsten | Other | Buy | 3,000 | 44,040.00 SEK |
| 2023-11-24 | Charlotte Vithlani Hansson | Other | Buy | 3,000 | 44,640.00 SEK |
| 2023-11-08 | Fredrik Järrsten | Other | Buy | 1,500 | 23,715.00 SEK |
| 2023-02-24 | Nikolaj Arrild Sørensen | Other | Buy | 11,500 | 188,945.00 SEK |
| 2023-01-27 | Fredrik Järrsten | Other | Buy | 4,500 | 79,695.00 SEK |
| 2022-07-26 | Michael Matly | Other | Buy | 2,820 | 60,777.77 SEK |
| 2022-07-21 | Charlotte Vithlani Hansson | Other | Buy | 3,000 | 61,500.00 SEK |
| 2022-07-15 | James Noble | Other | Buy | 18,500 | 394,252.80 SEK |
Peer Companies
